Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
3D Medicines, Inc. ( (HK:1244) ) has issued an announcement.
3D Medicines Inc. has announced a strategic cooperation agreement with Qingdao Hainuo, aimed at resolving ongoing legal disputes and fostering future collaboration. The agreement, valued at RMB98.0 million, led to the withdrawal of civil proceedings and the discharge of a Preservation Order, thereby enhancing the company’s operational and financial stability.
More about 3D Medicines, Inc.
Average Trading Volume: 247,060
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.3B
See more data about 1244 stock on TipRanks’ Stock Analysis page.